Advisory
Committees
Nature and Basis Statements of Conflict(s)
of Interest for Voting Members of FDA Advisory Committee Members
The Agency is revising its procedures
regarding the disclosure of conflicts of interest and waivers for
voting advisory committee members in order to implement the requirements
of section 795 of Pub. L. No. 109-97 (Agriculture, Rural Development,
Food and Drug Administration, and Related Agencies Appropriations
Act, 2006) (Nov. 10, 2005). This information is being provided as
an interim measure to comply with the requirements of this law.
Cardiovascular and Renal
Drugs Advisory Committee
September 21, 2006
David DeMets, Ph.D.
• 18 U.S.C. 208 waiver [pdf]
• Acknowledgement and Consent [pdf]
John Ellis, M.D.
• 18 U.S.C. 208 waiver [pdf]
• Acknowledgement and Consent [pdf]
John Flack, M.D.
• 18 U.S.C. 208 waiver [pdf]
• Acknowledgement and Consent [pdf]
Page updated:
September 5, 2006
|